Clinical Trial

Budesonide Irrigation in Allergic Rhinitis

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 21, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Topical nasal steroids are significant therapeutic options for allergic rhinitis (AR). The distribution of intranasal steroid spray (INS) administration is less than that of irrigation. However, the available data on steroid nasal irrigation is limited. This article aims to evaluate the efficacy and adverse effects (AEs) of steroid irrigation in AR patients.
Trial Details
NCT Number NCT06785662
Lead Sponsor Siriraj Hospital
Conditions Allergic Rhinitis
Enrollment 78 participants
Start Date 2025-02-12
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-21